Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 9
2007 7
2008 10
2009 23
2010 11
2011 8
2012 5
2013 6
2014 9
2015 5
2016 2
2017 8
2018 2
2019 4
2020 2
2023 2
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 36596599

101 results
Results by year
Filters applied: . Clear all
Page 1
Bone turnover markers to monitor oral bisphosphonate therapy.
Ashcherkin N, Patel AA, Algeciras-Schimnich A, Doshi KB. Ashcherkin N, et al. Cleve Clin J Med. 2023 Jan 3;90(1):26-31. doi: 10.3949/ccjm.90a.22002. Cleve Clin J Med. 2023. PMID: 36596600 Free article. Review.
Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate.
Brown JP, Roux C, Ho PR, Bolognese MA, Hall J, Bone HG, Bonnick S, van den Bergh JP, Ferreira I, Dakin P, Wagman RB, Recknor C. Brown JP, et al. Osteoporos Int. 2014 Jul;25(7):1953-61. doi: 10.1007/s00198-014-2692-7. Epub 2014 Mar 28. Osteoporos Int. 2014. PMID: 24676847
[When should bisphosphonate treatment be discontinued?].
Eriksen EF, Halse J. Eriksen EF, et al. Tidsskr Nor Laegeforen. 2012 Aug 7;132(14):1630-2. doi: 10.4045/tidsskr.11.0788. Tidsskr Nor Laegeforen. 2012. PMID: 22875131 Free article. Norwegian. No abstract available.
101 results